{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:28:34Z","timestamp":1778527714365,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS065868"],"award-info":[{"award-number":["NS065868"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21DA030103"],"award-info":[{"award-number":["R21DA030103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["F-1390"],"award-info":[{"award-number":["F-1390"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.expneurol.2015.02.008","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T03:14:15Z","timestamp":1423883655000},"page":"42-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Overexpression of GRK6 rescues l-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats"],"prefix":"10.1016","volume":"266","author":[{"given":"M. Rafiuddin","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Bychkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghyi","family":"Kook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Zurkovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin N.","family":"Dalby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia V.","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.02.008_bb0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1471-4159.2007.05104.x","article-title":"Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by L-DOPA treatment","volume":"104","author":"Ahmed","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/jpet.107.131987","article-title":"Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation","volume":"325","author":"Ahmed","year":"2008","journal-title":"J Pharmacol. Exper Ther."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0005","doi-asserted-by":"crossref","first-page":"28ra28","DOI":"10.1126\/scitranslmed.3000664","article-title":"Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease","volume":"2","author":"Ahmed","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0020","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.0837-12.2012","article-title":"G\u03b1(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in l-3,4-dihydroxyphenylalanine-induced dyskinesia","volume":"32","author":"Alcacer","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0025","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pharmthera.2011.07.004","article-title":"Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease","volume":"132","author":"Armentero","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2009.04.005","article-title":"Striatal overexpression of DeltaJunD resets l-DOPA-induced dyskinesia in a primate model of Parkinson disease","volume":"66","author":"Berton","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2004.10.005","article-title":"l-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain","volume":"18","author":"Bezard","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0050","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/WNL.57.10.1829","article-title":"Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models","volume":"57","author":"Bibbiani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0060","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0055","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","article-title":"Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice","volume":"23","author":"Bohn","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0065","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2005.04190.x","article-title":"Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism","volume":"22","author":"Brown","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0080","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0075","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria","volume":"27","author":"Bruchas","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-4159.2007.04586.x","article-title":"Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum","volume":"102","author":"Bychkov","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neurobiolaging.2006.10.012","article-title":"Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia","volume":"29","author":"Bychkov","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0090","first-page":"1","article-title":"Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia","volume":"17","author":"Bychkov","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2011.07.009","article-title":"Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder","volume":"44","author":"Bychkov","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0100","doi-asserted-by":"crossref","first-page":"e48912","DOI":"10.1371\/journal.pone.0048912","article-title":"Distinct cellular and subcellular distribution of G protein-coupled receptor kinase and arrestin isoforms in the striatum","volume":"7","author":"Bychkov","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0110","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1523\/JNEUROSCI.0252-10.2010","article-title":"Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements","volume":"30","author":"Cao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in l-DOPA-induced dyskinesia","volume":"183","author":"Cenci","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0925s41","article-title":"Ratings of l-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"9","author":"Cenci","year":"2007","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0125","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroscience.2004.10.026","article-title":"Enhanced striatal opioid receptor-mediated G-protein activation in l-DOPA-treated dyskinetic monkeys","volume":"132","author":"Chen","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of Parkinsonism by chronic treatment with l-dopa","volume":"280","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.expneurol.2007.01.024","article-title":"The selective kappa-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates","volume":"205","author":"Cox","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits l-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"Beta-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Ann. Rev. Physiol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0165","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.neuropharm.2008.08.031","article-title":"Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat","volume":"55","author":"Dupre","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2011.02.012","article-title":"Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rat","volume":"229","author":"Dupre","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/cn300234z","article-title":"Effects of 5-HT receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats","volume":"4","author":"Dupre","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0180","article-title":"Selective inactivation of striatal FosB\/\u0394FosB-expressing neurons alleviates l-dopa-induced dyskinesia","author":"Engeln","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0185","doi-asserted-by":"crossref","first-page":"21824","DOI":"10.1073\/pnas.1012071107","article-title":"Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with l-dopa-induced dyskinesia","volume":"107","author":"Fasano","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0190","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1523\/JNEUROSCI.22-03-01054.2002","article-title":"Persistent behavioral sensitization to chronic l-DOPA requires A2A adenosine receptors","volume":"22","author":"Fredduzzi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0896-6273(03)00192-2","article-title":"Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice","volume":"38","author":"Gainetdinov","year":"2003","journal-title":"Neuron"},{"issue":"Suppl.","key":"10.1016\/j.expneurol.2015.02.008_bb0200","first-page":"S42","article-title":"Dopamine-mediated gene regulation in models of Parkinson's disease","volume":"47","author":"Gerfen","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0205","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2 kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0210","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1038\/sj.onc.1210407","article-title":"G protein regulation of MAPK networks","volume":"26","author":"Goldsmith","year":"2007","journal-title":"Oncogene"},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2015.02.008_bb0215","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.parkreldis.2004.11.005","article-title":"Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors","volume":"11","author":"Guigoni","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1460-9568.2005.04196.x","article-title":"Levodopa-induced dyskinesia in MPTP-treated macaque is not dependent of the extent and pattern of the nigrostrial lesion","volume":"22","author":"Guigoni","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0220","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nbd.2007.02.001","article-title":"Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates","volume":"26","author":"Guigoni","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0230","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/j.1460-2075.1996.tb00636.x","article-title":"Selective interaction of JNK protein kinase isoforms with transcription factors","volume":"15","author":"Gupta","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/gb-2006-7-9-236","article-title":"Arrestins: ubiquitous regulators of cellular signaling pathways","volume":"7","author":"Gurevich","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pharmthera.2005.09.008","article-title":"The structural basis of arrestin-mediated regulation of G-protein-coupled receptors","volume":"110","author":"Gurevich","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0240","series-title":"Dopamine Receptors","first-page":"525","article-title":"Dopamine receptors and the treatment of Parkinson's disease","author":"Gurevich","year":"2008"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0250","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/exnr.2001.7727","article-title":"\u03bc- and \u03b4-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"171","author":"Henrya","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0265","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cyto.2009.08.002","article-title":"Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination","volume":"48","author":"Huang","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0275","first-page":"1298","article-title":"Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs","volume":"275","author":"Iaccarino","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0280","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.expneurol.2013.09.003","article-title":"Modulating mGluR5 and 5-HT1A\/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action","volume":"250","author":"Iderberg","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-795-2_1","article-title":"The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions","volume":"661","author":"Keshet","year":"2010","journal-title":"Methods Mol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0300","doi-asserted-by":"crossref","first-page":"37409","DOI":"10.1074\/jbc.M106728200","article-title":"Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0295","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.neuroscience.2005.10.054","article-title":"Reversal of supersensitive striatal dopamine D1 receptor signaling and extracellular signal-regulated kinase activity in dopamine-deficient mice","volume":"137","author":"Kim","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0305","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0310","doi-asserted-by":"crossref","first-page":"16785","DOI":"10.1074\/jbc.M601327200","article-title":"The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs","volume":"281","author":"Lodowski","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0315","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/mol.51.5.800","article-title":"Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization","volume":"51","author":"Menard","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnana.2011.00051","article-title":"Striatal signaling in l-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation","volume":"5","author":"Murer","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0325","doi-asserted-by":"crossref","first-page":"e33806","DOI":"10.1371\/journal.pone.0033806","article-title":"The origin and evolution of G protein-coupled receptor kinases","volume":"7","author":"Mushegian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.09.013","article-title":"Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?","volume":"87","author":"Nadjar","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0335","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1074\/jbc.M209532200","article-title":"The nature of the arrestin\u00d7receptor complex determines the ultimate fate of the internalized receptor","volume":"278","author":"Pan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with l-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pavon","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0345","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1359\/jbmr.080110","article-title":"Doubly truncated FosB isoform (\u03942\u0394FosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity","volume":"23","author":"Sabatakos","year":"2008","journal-title":"J. Bone Moner."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0365","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0350","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-4159.2008.05831.x","article-title":"l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice","volume":"108","author":"Santini","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0360","doi-asserted-by":"crossref","first-page":"e12322","DOI":"10.1371\/journal.pone.0012322","article-title":"Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in l-DOPA-induced dyskinesia","volume":"5","author":"Santini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0355","doi-asserted-by":"crossref","first-page":"27806","DOI":"10.1074\/jbc.M112.388413","article-title":"Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism","volume":"287","author":"Santini","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0370","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the Rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0375","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/01.jnen.0000186922.42592.b7","article-title":"Coordinated and spatial upregulation of arc in striatonigral neurons correlates with l-dopa-induced behavioral sensitization in dyskinetic rats","volume":"64","author":"Sgambato-Faure","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002826-199704000-00001","article-title":"Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias","volume":"20","author":"Stocchi","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0385","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1021\/bi0348617","article-title":"Two rate-limiting steps in the kinetic mechanism of the serine\/threonine specific protein kinase ERK2: a case of fast phosphorylation followed by fast product release","volume":"42","author":"Waas","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0390","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","article-title":"Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease","volume":"98","author":"Wang","year":"2012","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0395","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of l-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0405","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1046\/j.1471-4159.1999.0731781.x","article-title":"Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression","volume":"73","author":"Willets","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0400","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1523\/JNEUROSCI.5506-03.2004","article-title":"Imaging of muscarinic acetylcholine receptor signaling in hippocampal neurons: evidence for phosphorylation-dependent and -independent regulation by G-protein-coupled receptor kinases","volume":"24","author":"Willets","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0410","doi-asserted-by":"crossref","first-page":"310318","DOI":"10.1016\/j.brainres.2010.08.099","article-title":"Deletion of adenosine A1 or A(2A) receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease","volume":"1367","author":"Xiao","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2015.02.008_bb0415","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/39068","article-title":"Prolonged photoresponses in transgenic mouse rods lacking arrestin","volume":"389","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.02.008_bb0420","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.0711839105","article-title":"Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in l-DOPA treatment of an animal model of Parkinsonism","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T06:13:40Z","timestamp":1717740820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":84,"alternative-id":["S0014488615000308"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.02.008","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of GRK6 rescues l-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}